Gilead Asked by House Democrats for Details on HIV Drug's Price

Bookmark
(Bloomberg) -- House Democrats sent a letter to Gilead Sciences Inc. seeking documents on pricing and patents for its HIV drug Truvada, whose high cost has drawn the ire of lawmakers and AIDS activ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.